{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T23:07:40Z","timestamp":1771024060045,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T00:00:00Z","timestamp":1535414400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["102-M2228, NTUH 104-M286"],"award-info":[{"award-number":["102-M2228, NTUH 104-M286"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["105-N3224, 104-S2710"],"award-info":[{"award-number":["105-N3224, 104-S2710"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["MOHW104-TD-B-111-04"],"award-info":[{"award-number":["MOHW104-TD-B-111-04"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13014-018-1099-6","type":"journal-article","created":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T18:34:13Z","timestamp":1535481253000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Prognostic significance of tumor-infiltrating lymphocytes in patients with operable tongue cancer"],"prefix":"10.1186","volume":"13","author":[{"given":"Wan-Yu","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Tu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keng-Hsueh","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsiang-Kuang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing-Shen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yih-Leong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Hsin","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann-Lii","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,28]]},"reference":[{"key":"1099_CR1","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/S0140-6736(08)60728-X","volume":"371","author":"A Argiris","year":"2008","unstructured":"Argiris A, Karamouzis MV, Raben D, Ferris RL. Head and neck cancer. Lancet. 2008;371:1695\u2013709.","journal-title":"Lancet"},{"key":"1099_CR2","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1126\/science.1203486","volume":"331","author":"RD Schreiber","year":"2011","unstructured":"Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science (New York, NY). 2011;331:1565\u201370.","journal-title":"Science (New York, NY)"},{"key":"1099_CR3","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nrc3245","volume":"12","author":"WH Fridman","year":"2012","unstructured":"Fridman WH, Pages F, Sautes-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer. 2012;12:298\u2013306.","journal-title":"Nat Rev Cancer"},{"key":"1099_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/bjc.2013.639","volume":"110","author":"MJ Ward","year":"2014","unstructured":"Ward MJ, Thirdborough SM, Mellows T, et al. Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer. Br J Cancer. 2014;110:489\u2013500.","journal-title":"Br J Cancer"},{"key":"1099_CR5","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1056\/NEJMoa051424","volume":"353","author":"F Pages","year":"2005","unstructured":"Pages F, Berger A, Camus M, et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med. 2005;353:2654\u201366.","journal-title":"N Engl J Med"},{"key":"1099_CR6","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1200\/JCO.2008.17.9036","volume":"27","author":"A Merlo","year":"2009","unstructured":"Merlo A, Casalini P, Carcangiu ML, et al. FOXP3 expression and overall survival in breast cancer. J Clin Oncol. 2009;27:1746\u201352.","journal-title":"J Clin Oncol"},{"key":"1099_CR7","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1200\/JCO.2006.09.4565","volume":"25","author":"Q Gao","year":"2007","unstructured":"Gao Q, Qiu SJ, Fan J, et al. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol. 2007;25:2586\u201393.","journal-title":"J Clin Oncol"},{"key":"1099_CR8","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/nm1093","volume":"10","author":"TJ Curiel","year":"2004","unstructured":"Curiel TJ, Coukos G, Zou L, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med. 2004;10:942\u20139.","journal-title":"Nat Med"},{"key":"1099_CR9","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1200\/JCO.2012.45.2052","volume":"31","author":"K Suzuki","year":"2013","unstructured":"Suzuki K, Kadota K, Sima CS, et al. Clinical impact of immune microenvironment in stage I lung adenocarcinoma: tumor interleukin-12 receptor beta2 (IL-12Rbeta2), IL-7R, and stromal FoxP3\/CD3 ratio are independent predictors of recurrence. J Clin Oncol. 2013;31:490\u20138.","journal-title":"J Clin Oncol"},{"key":"1099_CR10","doi-asserted-by":"publisher","first-page":"5052","DOI":"10.1200\/JCO.2006.06.4642","volume":"24","author":"AM Lee","year":"2006","unstructured":"Lee AM, Clear AJ, Calaminici M, et al. Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome. J Clin Oncol. 2006;24:5052\u20139.","journal-title":"J Clin Oncol"},{"key":"1099_CR11","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1200\/JCO.2011.39.9881","volume":"31","author":"P Greaves","year":"2013","unstructured":"Greaves P, Clear A, Coutinho R, et al. Expression of FOXP3, CD68, and CD20 at diagnosis in the microenvironment of classical Hodgkin lymphoma is predictive of outcome. J Clin Oncol. 2013;31:256\u201362.","journal-title":"J Clin Oncol"},{"key":"1099_CR12","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1200\/JCO.2008.18.7229","volume":"27","author":"P Salama","year":"2009","unstructured":"Salama P, Phillips M, Grieu F, et al. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol. 2009;27:186\u201392.","journal-title":"J Clin Oncol"},{"key":"1099_CR13","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1158\/1078-0432.CCR-05-1886","volume":"12","author":"C Badoual","year":"2006","unstructured":"Badoual C, Hans S, Rodriguez J, et al. Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers. Clin Cancer Res. 2006;12:465\u201372.","journal-title":"Clin Cancer Res"},{"key":"1099_CR14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/lary.22133","volume":"122","author":"D Wansom","year":"2012","unstructured":"Wansom D, Light E, Thomas D, et al. Infiltrating lymphocytes and human papillomavirus-16--associated oropharyngeal cancer. Laryngoscope. 2012;122:121\u20137.","journal-title":"Laryngoscope"},{"key":"1099_CR15","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s00262-011-1046-y","volume":"60","author":"S Ladoire","year":"2011","unstructured":"Ladoire S, Martin F, Ghiringhelli F. Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer. Cancer Immunol Immunother. 2011;60:909\u201318.","journal-title":"Cancer Immunol Immunother"},{"key":"1099_CR16","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/bjc.2013.640","volume":"110","author":"P Balermpas","year":"2014","unstructured":"Balermpas P, Michel Y, Wagenblast J, et al. Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer. Br J Cancer. 2014;110:501\u20139.","journal-title":"Br J Cancer"},{"key":"1099_CR17","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.oraloncology.2014.09.006","volume":"51","author":"GT Wolf","year":"2015","unstructured":"Wolf GT, Chepeha DB, Bellile E, et al. Tumor infiltrating lymphocytes (TIL) and prognosis in oral cavity squamous carcinoma: a preliminary study. Oral Oncol. 2015;51:90\u20135.","journal-title":"Oral Oncol"},{"key":"1099_CR18","doi-asserted-by":"publisher","first-page":"e167","DOI":"10.1016\/j.oraloncology.2009.05.640","volume":"45","author":"LV Distel","year":"2009","unstructured":"Distel LV, Fickenscher R, Dietel K, et al. Tumour infiltrating lymphocytes in squamous cell carcinoma of the oro- and hypopharynx: prognostic impact may depend on type of treatment and stage of disease. Oral Oncol. 2009;45:e167\u201374.","journal-title":"Oral Oncol"},{"key":"1099_CR19","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/1471-2407-9-292","volume":"9","author":"D Pretscher","year":"2009","unstructured":"Pretscher D, Distel LV, Grabenbauer GG, et al. Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+ B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma. BMC Cancer. 2009;9:292.","journal-title":"BMC Cancer"},{"key":"1099_CR20","doi-asserted-by":"publisher","first-page":"e38711","DOI":"10.1371\/journal.pone.0038711","volume":"7","author":"A Nasman","year":"2012","unstructured":"Nasman A, Romanitan M, Nordfors C, et al. Tumor infiltrating CD8+ and Foxp3+ lymphocytes correlate to clinical outcome and human papillomavirus (HPV) status in tonsillar cancer. PLoS One. 2012;7:e38711.","journal-title":"PLoS One"},{"key":"1099_CR21","doi-asserted-by":"publisher","first-page":"e71908","DOI":"10.1371\/journal.pone.0071908","volume":"8","author":"DT Weed","year":"2013","unstructured":"Weed DT, Walker G, De La Fuente AC, et al. FOXP3 subcellular localization predicts recurrence in oral squamous cell carcinoma. PLoS One. 2013;8:e71908.","journal-title":"PLoS One"},{"key":"1099_CR22","doi-asserted-by":"publisher","first-page":"859","DOI":"10.3109\/00016489.2014.918279","volume":"134","author":"H Hanakawa","year":"2014","unstructured":"Hanakawa H, Orita Y, Sato Y, et al. Regulatory T-cell infiltration in tongue squamous cell carcinoma. Acta Otolaryngol. 2014;134:859\u201364.","journal-title":"Acta Otolaryngol"},{"key":"1099_CR23","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s12026-014-8616-y","volume":"61","author":"C Zhuo","year":"2015","unstructured":"Zhuo C, Xu Y, Ying M, et al. FOXP3+ Tregs: heterogeneous phenotypes and conflicting impacts on survival outcomes in patients with colorectal cancer. Immunol Res. 2015;61:338\u201347.","journal-title":"Immunol Res"},{"key":"1099_CR24","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.tripleo.2009.12.015","volume":"109","author":"Y Watanabe","year":"2010","unstructured":"Watanabe Y, Katou F, Ohtani H, et al. Tumor-infiltrating lymphocytes, particularly the balance between CD8(+) T cells and CCR4(+) regulatory T cells, affect the survival of patients with oral squamous cell carcinoma. Oral Surg, Oral Med, Oral Pathol, Oral Radiol Endod. 2010;109:744\u201352.","journal-title":"Oral Surg, Oral Med, Oral Pathol, Oral Radiol Endod"},{"key":"1099_CR25","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1016\/j.ejca.2013.03.019","volume":"49","author":"C Nordfors","year":"2013","unstructured":"Nordfors C, Grun N, Tertipis N, et al. CD8+ and CD4+ tumour infiltrating lymphocytes in relation to human papillomavirus status and clinical outcome in tonsillar and base of tongue squamous cell carcinoma. Eur J Cancer (Oxford, England : 1990). 2013;49:2522\u201330.","journal-title":"Eur J Cancer (Oxford, England : 1990)"},{"key":"1099_CR26","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3892\/ol_00000023","volume":"1","author":"G Moreira","year":"2010","unstructured":"Moreira G, Fulgencio LB, DEM EF, et al. T regulatory cell markers in oral squamous cell carcinoma: relationship with survival and tumor aggressiveness. Oncol Lett. 2010;1:127\u201332.","journal-title":"Oncol Lett"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-018-1099-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13014-018-1099-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-018-1099-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T11:42:41Z","timestamp":1568979761000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-018-1099-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,28]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1099"],"URL":"https:\/\/doi.org\/10.1186\/s13014-018-1099-6","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,28]]},"assertion":[{"value":"7 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Research Ethics Committee of National Taiwan University Hospital (NTUH: 201412056RINC).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"157"}}